Blackwell Kimberly

CIK 00018164653 companiesPHILADELPHIA, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001816465

Recent Transactions

34 trades

Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2025-06-13+30,700→ 30,700 total
Award
Century Therapeutics, Inc.$IPSC
Stock Option (right to buy)
2025-06-12+44,000→ 44,000 total
Award
Century Therapeutics, Inc.$IPSC
Stock Option (right to buy)
2024-06-20+44,000→ 44,000 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2024-06-12+22,100→ 22,100 total
Tax Payment
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2024-02-01$11.69/sh−20,655→ 484,145 total
Award
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2024-02-01+250,000→ 504,800 total
Award
Zentalis Pharmaceuticals, Inc.$ZNTL
Stock Option (Right to Buy)
2024-02-01+250,000→ 250,000 total
Purchase
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2023-11-13$10.29/sh+5,000→ 254,800 total
Award
Century Therapeutics, Inc.$IPSC
Stock Option (right to buy)
2023-06-27+44,000→ 44,000 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2023-06-14+20,500→ 20,500 total
Award
Zentalis Pharmaceuticals, Inc.$ZNTL
Stock Option (Right to Buy)
2023-02-01+355,200→ 355,200 total
Award
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2023-02-01+244,800→ 249,800 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2022-06-15+15,000→ 15,000 total
Award
Century Therapeutics, Inc.$IPSC
Stock Option (right to buy)
2022-06-09+19,872→ 19,872 total
Award
Zentalis Pharmaceuticals, Inc.$ZNTL
Stock Option (Right to Buy)
2022-05-16+427,202→ 427,202 total
Award
Zentalis Pharmaceuticals, Inc.$ZNTL
Stock Option (Right to Buy)
2022-05-16+1,708,809→ 1,708,809 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2022-01-03$83.74/sh−1,000→ 5,000 total
Exercise/Conversion
Zentalis Pharmaceuticals, Inc.$ZNTL
Stock Option (Right to Buy)
2022-01-03−1,000→ 38,000 total
Exercise/Conversion
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2022-01-03$47.80/sh+1,000→ 6,000 total
Exercise/Conversion
Zentalis Pharmaceuticals, Inc.$ZNTL
Stock Option (Right to Buy)
2021-12-01−1,000→ 39,000 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2021-12-01$81.84/sh−1,000→ 5,000 total
Exercise/Conversion
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2021-12-01$47.80/sh+1,000→ 6,000 total
Exercise/Conversion
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2021-11-01$47.80/sh+1,000→ 6,000 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2021-11-01$80.46/sh−1,000→ 5,000 total
Exercise/Conversion
Zentalis Pharmaceuticals, Inc.$ZNTL
Stock Option (Right to Buy)
2021-11-01−1,000→ 40,000 total
Exercise/Conversion
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2021-10-25$47.80/sh+1,000→ 6,000 total
Exercise/Conversion
Zentalis Pharmaceuticals, Inc.$ZNTL
Stock Option (Right to Buy)
2021-10-25$47.80/sh−1,000→ 41,000 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2021-10-25$77.59/sh−1,000→ 5,000 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2021-06-23+47,132→ 47,132 total
Award
Century Therapeutics, Inc.$IPSC
Option (right to buy)
2021-06-17+19,872→ 19,872 total
Award
Zentalis Pharmaceuticals, Inc.$ZNTL
Stock Option (Right to Buy)
2021-06-04+15,000→ 15,000 total
Award
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2021-06-04+5,000→ 5,000 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2021-04-12+7,081→ 7,081 total
Award
Zentalis Pharmaceuticals, Inc.$ZNTL
Stock Option (Right to Buy)
2020-07-01+42,000→ 42,000 total

Companies

Recent Filings

Address

C/O CENTURY THERAPEUTICS, INC. 25 N 38TH STREET, 11TH FLOOR

PHILADELPHIA, PA, 19104

View on SEC.gov